Anti-cancer strains

Anti-cancer Strains:
Theoretically strains could be engineered to detect precancerous and early stage detected tumours and use these CRISPR attacks to alter the DNA of pre cancerous cells and tumours to inhibit,stunt or limit their growth keeping them at a desired size and prevent them spreading to the rest of the body as well as fix the mutations that caused them to arise in the first place or undergo apoptosis to allow for chemotherapy and other treatments to be more effective as well as less intensive for the patient or even insert suicide genes with these even injected into a person prior to developing cancers that are environmentally caused(ie lung cancer),those that are the result of CRISPR treatments or even induced pluripotent stem cell treatments and those that are genetically predisposed with recombinant DNA from endolithes and protein coats from the host species or patient and resistance to antibiotics and cancer treatments such as chemotherapy(not passed onto pathogens) ensuring they can survive in the body for decades prioraAfter they occur as a living vaccine that attack cancer cells the instant they form with sensors,receptors and proteins that only allow them to detect and intercept cancer cells with immunotherapy methods and CD4+ T Cells,NKT cells,T lymphocyte and cytotoxic T cells strengthened or recombinant DNA from these added to these microbes to make them detect cancerous and precancerous cells instantly and their location through detecting specific biomarkers including CD47 via tweaked C.elegans DNA.The location of tumours will be detected by them and/or them flooding the bloodstream and lymphatic system to reach hard to reach tumours.They can also program the primary system utilise the same anti-cancer compounds they produce.Ideally these microbes would have DNA from T.gammatolerans and D.radiodurans to make them survive radiation treatments and others to survive chemotherapy within their capsid so as to allow these treatments to be applied in less intensive treatments over longer periods of time with tumours have radioresistance removed.They would have DNA from all types of extremophiles like acidophiles,alkanophiles and even Tardigrade to survive all types of extreme conditions in the human body including the stomach and the rest of the gastro-intestinal tract.The ability of them to survive radiation,low temperatures and chemotherapy treatments can also be through horizontal gene transfer be added to the host via gene therapy in strains that can only interact with the host and not bacteria to make healthy cells unaffected by these treatments lessening the intensity of these treatments.Chemotherapy that needs to applied less intensively to deal with aggressive tumours can involve more benign compounds less toxic to human released as nanoparticles by implants or even the microbes themselves synthesised by them,injected by needles in carbon spherical buckyballs that are released over long periods of time or by nanorobots.These can also use the same technologies as photoanti-microbial versions of these to release reactive oxygen,ascorbic acid,brazillian wasp and scorpion venom or biological compounds used in chemotherapy released as nanoparticles,flooded into the bloodstream and lymphatic system if deemed safe on the humans hosts cells or ideally when they latch onto the tumours that kill or stunt the growth of precancerous and cancerous cells alongside the insertion of CRISPR treatments that stunt their growth,undergo apoptosis to again make conventional treatments less intensive.To deal with tumours in their pre cancerous stage they using tweaked recombinant DNA from C.elegans to detect different biomarkers especially CD47 and flood the body including the lymphatic and circulatory system with anti-cancer compounds such as those from Polybia paulista that kill cancer cells but not healthy cells thus allowing this to spread to every major organ in the body with them apply them as nanoparticles and on the surface if they actually reach them on time as well this flooding techniques as a means of dealing with tumours that grow quickly and are in hard to reach areas such as brain and inoperable tumours and those as a result of carcinogens and skin cancer and those that occur in hard to reach places such as the brain and underneath the skin.The universal receptors of C.elegans in them could be programmed to detect all cancer biomarkers CD47 etc to be used to determine the presence a tumour or precancerous tumour and thus its location via chemothaxis.This can be replicated with those programmed to detect precancerous and cancerous tumours using recombinant DNA from human CD4+ T Cells,NKT cells,cytotoxic T cells,T lymphocyte from scratch and immunotherpary treatments can be engineered to produce these dyes and bioluminesce to create reactive oxygen or biological compounds that could kill or stunt the growth of cancers with these being ascorbic acid or biological compounds used in chemotherapy synthesised by them using DNA crops rich in ascorbic acid or from scratch including bio based compounds in place of synthetic ones alongside DNA from crops that produce antioxidants and compounds that inhibit the growth and spread of or prevent tumours forming again synthesised when pre-cancerous and cancerous cells are detected with them engineered alongside the primary immune system to be able to detect both all cancer biomarkers and also pre cancerous and cancerous tumours and their location.Ideally the cancer strains or even base microbes would have universal receptors from C.elegans and when they detect biomarkers would intake the compounds and through mechanotransduction or reverse mechanotransduction,chemical reactions seen in more complex or similarly simple organisms and simple and complex neural clusters and systems in them would be able to send via nanomachines and biosynth wifi the structure of the compound that be cross referenced with Physis to determine what is and what biomarker for which specific cancer it is and also the presence of CD47 and thus have anti-cancer strains multiply and using chemothaxis locate the location of the tumour in its precancerous or early state allowing them to use relevant compounds to stunt its growth and kill them before they enter either stage 0 or 1 stages years or even decades before they can be detected via both symptoms and even conventional screening such as xrays,blood tests and even biopsies meaning a person would be cured of a tumour before it forms without even realising it with them logged into their patient file.Paean can using biosynth WiFi determine the location of tumours even precancerous ones detected via home test kits,universal receptors on microbes,automated labs and Xray/MRI scans direct the anti-cancer strains to their exact location with them using flagellum to move around quickly and them then applying CRISPR treatments and anti-cancer compounds.These antioxidants,ascorbic acids and biological based chemotherapeutic compounds,protein based drugs using mRNA therapy,cannaboid oils,interferon gamma,Romidepsin(from Chromobacterium violaceum),bee(Melittin from A.mellifera)/scorpion(TsAP-1 from T.serrulatus)/snake(contortrostatin from Agkistrodon contortrix)/brazillian wasp(Polybia-MP1 from the venom of P.paulista) engineered by them using DNA from these arthropods will be either released into the bloodstream in large amounts as nanoparticles covered in protein bumpers to flood the bloodstream and lymphatic system or when the microbes attach themselves to tumours to be released on the surface of the microbe,inserted into cancerous cells or again as nanoparticles in localised flooding again to kill them or stunt their growth without harming healthy cells by not being released into the bloodstream with them released when they interact with the surface of the tumours at the same time that CRISPR treatments are applied to weaken them and stunt growth preventing them from growing or spreading.Polybia-MP1s advantage is that it can kill off tumours in a matter of seconds by attacking the unique phospholipids of tumours and causing key molecules for its survival to leak out with it not affecting healthy cells leaving no side effects.It can thus use the lymphatic system and bloodstream to reach hard to reach places of all types of cancers and since they kill all types of tumours can eradicate all types with this also used to prevent the tumours spreading by affecting all tissues at once killing them before they spread and since a permanent part of the hosts body would instantly fight off any new tumours that occur instantly rendering all existing cancer treatments defunct.TsAP-1 and melittin used by the microbes in bumpers can stunt the growth of tumours and thus be used to prevent them spreading across the body and growing in size making surgery,radiation and chemotherapy treatment more viable and effective and allow Polybia-MP1 treatments used by them to be more effective by allowing it to kill them off when they are in a stunted state preventing them spreading.The TsAP-1,melittin may be used to stunt the growth of tumours with them then removing the tumours accelerated healing genes via CRISPR in order to prevent it growing back if the DNA from A.mexicanum etc would cause destroyed tumours to grow back and then they would utilise Polybia-MP1 to kill off the tumour.All of these compounds will be applied by anti-cancer strains due to them being the ideal vector that can apply them directly onto the tumours surface via the microbes attaching to the tumours surface and releasing the compounds as nanoparticles directly onto the surface of tumours or even into the tumours internal cellular structures or via them released into the bloodstream in vivo as nanoparticles covered in bumpers with both measures done to prevent toxicity and them breaking down in the body.Once the tumour is destroyed by Polybia-MP1 the stem cell strains would form new tissues in their place with them having the accelerated healing phenotype returned to the new cells.This should be the best means of dealing with tumours and can deal with them in their early stages and can allow multiple tumours in different parts of the body to be dealt with and killed off at once if they have spread and be effective to terminal stage 3 or 4 patients since the strain can undergo mitosis via DNA from bacteria that do so and have flagellum engineered into them this will allow them to create millions of copies and travel to all parts of the body attacking them all at once very quickly to prevent them spreading any further with them fighting off any new tumours instantly years later if they bounce back.Radiorestence may be removed from tumours as well to allow the patient to be blasted with doses of radiation as high as 500-2,000Gy that would kill the tumour and not affect healthy cells with no side effects provided the rest of the body has this radiorestence kept.Thus TsAP-1,melittin,Polybia-MP1 and will be the main compounds used to fight cancer in these strains used together with the relevant DNA from P.paulista,A.mellifera and T.serrulatus added and will use the bloodstream and lymphatic system to spread these compounds covered in bumpers that interact only with the phospholipids of tumours to all parts of the body to prevent tumours spreading and can use localised flooding to kill off stage 0 to 4 tumours.If need be this strain can produce the other aforementioned compounds as well for backup all at once alongside synthetic compounds created by anabolic and catabolic reactions.The bumpers can prevent Polybia-MP1 breaking down in the bloodstream and prevent TsAP-1 and melittin harming cells via cytoxicity with the anti-cancer strains being the perfect vector to create them onsite of tumours limiting cytoxicity and them breaking down in the bloodstream.The main advantage of these microbes is that they will be able to flood the bloodstream and lymphatic system with anti-cancer compounds mainly Polybia-MP1 as nanoparticles covered in bumpers if tumours spread with the compounds reaching all major organs and hard to reach places of the body such as the brain,prostrate and cervix killing or stunting the growth of any tumours and or precancerous cells that may have already spread with these released once they detect biomarkers namely CD47 and since these will be inhabiting all tissues of the body allowing them to instantly attack tumours and precancerous cells that appear anywhere on the surface or by flooding the localised surrounding area with nanoparticles of the anti-cancer compounds at its disposal to prevent the compounds overrunning the body and attach to tumours to apply them via nanoparticles almost instantly when detected.This means a person could be cured of tumours in their early stages and precancerous stages without even realising it ever formed thus dropping the death rates from all forms of the disease significantly especially if they attack any new tumours instantly and use the lymphatic system to flood the entire body to attack tumours that spread from one place to the other by preventing them spreading.Tests on animals would show if tumours could regrow form this treatment if they have accelerated healing from A.mexicanum with if need be this removed from tumours via CRISPR before attacked.This should be possible if they are tweaked to detect CD47,antigens and all biomarkers of all types of cancers via C.elegans DNA with the same receptors etc as in immunotherapy with receptors for all types of tumours present on each one to inject them onto the surface of the tumours or produce the compound as nanoparticles either covered in bumpers of not and if injected into all patients worldwide prior to them even getting cancer rather than after unlike immunotherapy and once this strain passes from one generation to the next from first generation patients ensuring protection from the disease the second it forms with new tumours also attacked instantly.The venom based compounds would be applied by the microbes via receptors including synthetic ones added via scratch DNA similar to Car-T immunotherapy with each individual microbe of this strain having receptors for each type of tumour or there being sub strains of this strains for this with the option of creating nanoparticles covered in bumpers that prevent side effects and the compound breaking down or localised flooding next to tumours.Thus all patients worldwide will be injected with anti-cancer strains prior to being diagnosed as early as 2029 or 2025 for those with genetic predispositions.This method of flooding the lymphatic system and bloodstream would allow the compounds to spread to all areas of the body and kill tumours in hard to reach places and prevent them spreading to any parts of the body by flooding all possible areas it could spread to,killing any tumours that use the lymphatic system to spread and kill any that have spread with the excess released from the body through urine with zero side effects.This would be of benefit to patients with what would now be considered terminal,inoperable and stage 3 and 4 cancers of all types and reach tumours that have spread before they can or if they had in hard to reach areas with the primary immune system augmented through the microbes sharing genes to make them better at detecting and fighting cancerous and precancereous cells alongside either before they form as well as releasing chemicals when the microbes find them,program the immune system via sharing genes with the leukocytes and area in the host responsible for creating them to be able to detect specific or all biomarkers of all cancers etc to like with pathogens prevent the primary immune system from becoming too lazy.New chemotherapeutic and anti-cancer compounds can be created from scratch by Phanes,Epione and Paean creating necessary genotypes that can be use alongside them to produce desired effects with those discovered from nature done by adding recombinant DNA extracted by automated lab workers and automated machines once and then input into a base microbe that can grown in automated labs and sent to new patients to inserted into their microbes by automated machinery or synthesised from scratch Phanes,Epione etc.Polybia-MP1 from P.paulista using recombinant DNA from this athropod should be the main compound of anti-cancer strains as it attacks the unique phospholipids of tumours killing them within seconds without affecting healthy cells and can thus use the lymphatic system and bloodstream to reach hard to reach places of all types of cancers and since they kill all types of tumours can eradicate all types with this also used to prevent the tumours spreading by affecting all tissues at once killing them before they spread and since a permanent part of the hosts body would instantly fight off any new tumours that occur instantly rendering all existing cancer treatments defunct with any damaged tissue regrown by the body,microbes forming new tissue or accelerated healing added to the hosts genome via recombinant DNA from Planarians,Hydra and A.mexicanum.Flooding the lymphatic system and bloodstream with nanoparticles of it with or without bumpers can allow it to reach hard to reach places as well as flood the body for a significant amount of time can prevent tumours spreading by having all areas it could spread to flooded with the compound with them instantly killed if they do spread.Any new tumours that arise will be attacked instantly.Ideally to do this more effective once a tumour is detected the microbes can undergo massive replication to spread to all areas of the body and do this at the same time instantly or when another tumour is detected with excess ones then entering endospores and then flushed out of the body.By utilising chemotaxis they will be able to determine the location of tumours through levels of CD47 and other biomarkers with them designed to only attack tumours and not the host itself with them using chemical signals to control the primary immune system either strengthen with immunotherapy or not to attack only tumours and show them their location and not overeact and attack the host themselves and also initiating their attacks and ending them to prevent them going out of control with this also applying to bacterial and viral infections.Any immune responses that would damage the hosts such as cytokine storms,anaphalactic shock or allergic reactions of all types will be in time made redundant from accelerated healing,microbes repairing tissues and the primary immune system controlled through chemical signals from microbes stopping these from happening and CRISPR treatments with patient file DNA scans checking who is prone to this.Ideally Car-T immunotherapy will be modified to attack all tumours using Polybia-MP1 with it applied using horizontal gene transfer and advanced gene drive technology with this replacing those that are initiated by drugs with the immunotherapy controlled by the microbes via chemical signals.Thus all patients worldwide including those who have no predisposition at all will also be inoculated with these strains prior to getting cancer to ensure any tumours that arise by genetics,by exposure to carcinogens,oncoviruses and by pure chance ie random breaks will be treated instantly in their early stages with DNA mutations caused by pure chance,carcinogens etc corrected by CRISPR after the cancer is treated.Gene therapy that applies genes from Archaea that exhibit self repair etc will be applied to the cells in the body affected by tumours and around them to prevent the tumours rebounding and repair damaged DNA.Those with HIV will be have these strains present as backup as well.Those with predispositions will have them while CRISPR removes genetic predispositions.Once tumours have disappeared then excess microbes would be flushed out of the body enter and endospore state or undergo apoptosis leaving only a few behind.Since it kills all types of tumours indiscriminately based on their unique phospholipids Polybia MP-1 should be effective at all forms of the disease whether pancreatic,prostrate,cervical,brain,breast and lymphoma etc.If it doesn’t kill them indiscriminately then CRISPR treatments utilised by this strain that interact with the DNA in tumours can be applied via microbes to alter the DNA of tumours making them susceptible to this and other venom based proteins and thus destroy it with other proteins from venoms as detailed used by these cancer strains to also kill them and halt their growth.That would involve the CRISPR treatments changing the tumours DNA to exhibit the same phospholipids as tumours affected by it to then allow them to work with trials involving mice and chimpanzees with human DNA engineered to express all types of cancers tested to see which tumour types they can destroy and which will need CRISPR treatments to be killed by the compounds.The compound despite killing tumours leaves healthy cells unaffected with little to no side effects.Thus Polybia-MP1 will be the main compound used by anti-cancer to cure all types of cancers in patients suffering from stages of 0-4 of the diseases.Anti cancer strains of microbes would be the ideal vector for Polybia-MP1 and its other anti cancer compounds due to them being based on a patients leukocytes would allow them to stay in the body at all times without illiciting an immune response,their sensors that detect cancer biomarkers will detect them in precancerous states and also determine their exact location alongside Paean with flagellum engineered into them allowing them to travel to tumours across the entire body especially with their ability to undergo mitosis allowing them to do so and travel to multiple tumours at once with them applying compounds in the surface of tumours or as bumpers to prevent them breaking down in the body or causing cytoxicity.The presence of flagellum will allow for them to travel to the site of tumours quickly and the ability to undergoe mitosis will allow them to create millions of copies that will allow them to travel to multiple tumours spread across the body thus allowing for all tumours to be killed at once within seconds by applying Polybia MP-1 to the surface of tumours that will negate the problem of it breaking down in the body.This would allow them to attack and kill multiple tumours at once to kill off those that have spread across the body or those that have developed in multiple parts of the body.These anti cancer strains will be present in the body at all times even in patients without cancers to allow them to detect them in their early stages so as to kill them off on their precancerous stage or early stage to prevent them spreading or affect the host.They will also be present to kill tumours if they pop back up after months or years of remission.


https://www.youtube.com/watch?v=boYqzM8V4Uc

These anti-cancer strain will also apply CRISPR treatments that will also cause tumours to undergo apoptosis and also those that slow down and halt their spread by slowing their growth or stopping them growing at all.It can involve the removal of genes that give the tumours the ability to produce telomerase at all and those that produce and store key nutrients and compounds as well as functions that are key to their immortality and even growth and survival thus halting their growth and spread.Thus anti-cancer strains can via ribosomes and in particular plasmids apply CRISPR treatments that cause them to undergo apoptosis this committing suicide and those that remove genes key to their growth and survival thus stunting their spread and growth and kill them off with them replaced by new tissues created by the stem cell strain.Horizontal gene transfer will be used with taq polymerase allowing CRISPR treatments present in ribosomes and in particular plasmids to be recreated over and again.Endolithic bacterial DNA added to the tumours genome may slow down tumour growth exponentially this slowing down their growth and also their spread throughout the human body with this first tested in animals and tissue trials with terminator genes used by Monsanto etc or suicide genes used to make tumours undergoes apoptosis.The genes responsible for overproduction of teleomerase etc can be removed thus stunting the growth snd spread of tumours.If possible scratch DNA can be added to tumours that make tumours surfaces and internal structures susceptible and killed off by natural compounds such as vitamins and those found in medicinal marijuana,herbal teas etc and also penicillin and other everyday medications that are non toxic to healthy cells that can consumed,inhaled or injected into the bloodstream and spread by the bloodstream.This would involve genes created from scratch by Phanes that alter the phospholipids of tumours that can make them killed by over the counter drugs.The tumours can be made to express the same phospholipids in their outer structures as benign bacteria that are not resistant to antibiotics thus allowing antibiotics such as penicillin to be used to kill the tumours administered in pill form,injection or synthesised by the microbes.TsAP-1 and melittin will be applied to the tumours to also stunt their growth and spread with again CRISPR treatments added to again improve their efficacy thus preventing the tumours from spreading allowing for other treatments such as surgery,radiation and conventional chemotherapy.Thus this strain will utilise all of the aforementioned venoms that are applied using bumpers and also flooding by themselves

A combination of using Polybia-MP1 and even TsAP-1,melittin using relevant recombinant DNA from P.paulista,A.mellifera,T.serrulatus ane CRISPR treatments will allow the anti-cancer strains cure patients if any form of cancer.Thus these strains will be able to cure cancer patients of all forms of the disease with little to side effects.Immunotherapy can be applied to all patients prior to tumours forming especially those with genetic predispositions with Car-T applied to them via horizontal gene transfer,advanced gene drive technology and automated machinery to act as backup and save costs with this ideally engineered to use Polybia-MP1 and even TsAP-1,melittin using relevant recombinant DNA from P.paulista,A.mellifera,T.serrulatus as well to improve success.This will negate the need for the need of using drugs to apply and use immunotherapy in all patients that can have side effects and cant be used in patients suffering pre-exisitng conditions such as Crohn’s disease.Crohn’s disease and other conditions that limit one to avails of this can be treated via CRISPR,immunising them against Mycobacterium avium subspecies paratuberculosis etc to allow them to avail of this with as stated using horizontal gene trnasfer and advanced gene drive technology will allow Car-T immunothearpy to perfected and pass from one generation to the other and have them the compounds from P.paulista,T.serrulatus produced with them controlled by microbes to prevent overreactions and them attacking the body.This will allow for imunotherapy that doesnt require the use of drugs.Until then existing methods can be made much cheaper via 3D DNA printing and phlebotomy robots extracting and modifying the patients hosts cells or using blank leukocytes as a baseline wherein the patients DNA and those from P.paulista and those necessary to create the receptors and undergo mitosis and nothing else are added to create a primary immune system that will fight alongside the microbes with these automated measures cutting down on costs especially labour costs allowing them to be quickly created.All of these or at least most of them would be in an endospore state(ideally in this case groups of them switching from endospore to awoken state and having DNA from oligotrophs and xerophiles)to limit their resource use and would be awoken from the presence of biomarkers and signals from the other strains to use its anti-cancer compounds and once the precancerous and cancerous cells are gone they would revert back to an endospore.By 2029 Car-T immunotherapy will be passed onto all patients worldwide via horizontal gene transfer and modified to detect all types of cancer with again receptors for each one before tumors form with them controlled by Paean through chemical signals from microbes to attack only tumours when they arise and not attack the hosts preventing overreactions.Horizontal gene transfer can allow for all types of immunotherapy to be added with them also like microbes having the ability to enter endospores and even undergo mitosis and be flushed out with them added via horizontal gene transfer cutting down on costs to add this to all patients worldwide and alleviate work done by cancer strains.Techniques used in immunotherapy,mRNA therapy would be engineered into them to further enhance their ability to detect and fight cancers with this done alongside mRNA and immunotherapy built into the primary immune system with the primary immune system fitted with features of these microbes including the recombinant DNA from C.elegans.Having the primary immune system enhanced with mRNA therapy and Car-T immunotherapy will prevent it becoming lazy and allow each other to work together to alleviate strains on each other and even act as backup with aspects of the primary immune system that fight cancer fitted with this and other cancer fighting compounds with them even fitted with DNA from the plants and animals that create the microbes venoms.Ideally all patients regardless of their genetic screening will in time have this and the ability to detect pre cancerous and cancerous cells via these microbes inserting this via horizontal gene therapy into the primary immune system via the hosts genome to ensure the primary immune system is prepared for any cancers brought on by radiation,carcinogens etc with all microbes in all patients having this inherent phenotype of mRNA immunotherapy to alleviate strains on the microbes and also act as a backup and fight the disease alongside the microbes.Ideally this should begin at birth and not just adults with advanced gene drive technology will make this a permanent part of the human genepool and would save costs and labour in current immunotherapy techniques as it would be done in vivo and this would attack cancers in their early stages with ideally the leukocytes programmed to house relevant receptors for each type of cancer and utilize Polybia-MP1.This can be all types of immunotherapy including mRNA and also Car-T used to carry the compound to hard to reach places and as stated enhance the primary immune system preventing it becoming lazy.To cut costs in conventional methods ones leukocytes could be extracted via phlebotomy robots with 3D printing and other automated machinery engineering them to be then reinserted via phlebotomy robots and also vials at home with measures made to make this automated via AI and machinery cutting down costs and labour dramatically thus allowing for patients to this already with even patients who dont have cancer have this done to have them engineered to detect all types of cancer including those they are genetically predisposed to with all work done by AI and automated machinery with the same done to get any infusions they need overtime.Microbes can also aid in this by inhibiting the production of CD47 by tumours that prevents the immune system recognising tumours by them using gene therapy via horizontal gene transfer or creating counter proteins to remove the tumours ability to hide from the immune system allowing immunotherapy to work more effectively.If possible a persons entire body would have genes added to prevent any tumours that arise unable to produce CD47 again via advanced gene drive technology will become a permanent of the human genepool.To cut costs as stated before this ones leukocytes could be extracted via phlebotomy robots through leukophoresis with 3D DNA printing and other automated machinery engineering them to be then reinserted via phlebotomy robots and also vials at home with measures made to make this automated via AI and machinery cutting down costs and labour dramatically thus allowing for patients to this already with even patients who dont have cancer have this done to have them engineered to detect all types of cancer including those they are genetically predisposed to with all work done by AI and automated machinery with the same done to get any infusions they need overtime.3D DNA printers can print out DNA into blank leukocytes to quicken things up.In time gene therapy can be used to transfer this ability using synthetic receptors and Polypbia MP-1 to native T cells with gene drive technology making it a permanent part of the immune system.This can be possible by at least 2024-2025.Thus gene therapy would be used to transfer the ability to utilise immunotherapy via microbes to all patients before cancers arise.Those with genetic predisposition to cancer through screening should have traditional immunotherapy applied to them before the get cancer with CRISPR also used to remove the relevant genes.Also all of the worlds human patients can be engineered to produce bio based antioxidants and vitamins that come from plants and animals either in their primary immune system or just by the body in response to cancer biomarkers detected by them with the primary immune system engineered to be able to detect the presence of precancerous tumours and tumours themselves via horizontal gene transfer.Synthetic compounds to treat them can be created by them carrying out anabolic and catabolic reactions using excess nutrients in stores etc and also bio based compounds,plant and animal oils and hydrocarbons created by the same strain or the body from CRISPR treatments as well as amino acids synthesised by the body and diet.Thus it will be used to create gene therapy treatments,vaccines for all major viruses,bacterial pathogens,genetic diseases in living individuals and their children and also even cancers.

Prior to the development of nanomachines it may be possible for external chemical signals delivered to the patient to initiate and stop the release of anti-cancer compounds to be done by injection of them directly or within non master nanomachines to utilise compounds to control their release with as stated this sufficing until Paean and nanomachines becoming sufficiently advanced with this done when the biomarkers or the tumours and precancerous cells are detected via frequent home test kits and even MRI and xray scans.Furthermore prior to the develompent of nanomachines to alert the patient to signs of precancerous detected by them instantly via them inhabiting all areas of the body and also containing recombinant DNA from C.elegans tweaked to detect all cancers biomarkers and CD47 synonomous with tumours using the same method of immunotherapy and the native immune system as well as genes from scratch in ppb or even ppt and ppq they could relay their detection to the host via producing their own benign chemicals or hormones into the blood stream that produce unique symptoms to the patient such as uniquely coloured or smelling urine and feces,sweat with a specific odor or other symptoms either one or numerous that are unique to indicating cancer or specific cancers that can be use to alert the patient that they have precancerous cells with if possible toilet test kits that detect biomarkers also used.These hormones or chemicals should also be able to be picked up by toilet,swab and dongle based test kits to allow Paean to be alerted instantly.Upgrades can allow for more advanced microbes able to detect and attack precancerous and fully formed tumours while this primitive method is used.The microbes would be able to attack tumours by overriding attempts of tumours to trick the immune system to stop fighting them with the improved immune system via immunotherapy also overriding these attempts thus preventing the tumours growing too much.Inhibiting the production of CD47 can be done by them using gene therapy via horizontal gene transfer to remove the tumours ability to hide from the immune system allowing immunotherapy to work more effectively.Microbes and immune system would ideally have to be tweaked to be able to detect CD47 in the levels synonomous with tumours alongside biomarkers to not only detect them but also their location via chemotaxis and inhbit them via counterproteins or breaking them down but also gene therapy via CRISPR to shut this off.They could use this to initiate flooding of the entire area with anti-cancer compounds.If possible a persons entire body would have genes added to prevent any tumours that arise unable to produce CD47 prior to them occurring as well as even producing signals to in fact alert the immune system to its presence with this passing from one generation to the next with if need be its other essential functions in healthy cells kept or replaced by a similar protein to carry out its other benign functions.This should be done to all patients worldwide.This could suppress their growth and and spread into actual cancer by another few years or even decade ontop of the original decade that it would have taken the precancerous cells to form into cancer cells if both the use of anti-cancer compounds and CRISPR treatments are successful and then allow immunotherapy,radiation,chemotherapy and surgery to be used more precisely and less intensively thus possibly giving a person 15-20 years to get live saving treatment).Thus these microbes since living in the body indefinitely will constantly attack and treat any cancers that arise over ones lifetime with this including those that are environmentally caused,genetic,random mutations as well those caused by any treatments such as faults that arise from CRISPR treatments that they would fix etc.CRISPR can also be used to make precancerous cells and tumours once their growth is stunted to be made susceptible to the compounds that are killed off by them with the area that had tumours replaced by new Furthermore they could apply CRISPR treatments that would stunt their growth,slowing or even halting their growth completely stopping them getting bigger or even spreading or undergo apoptosis.This could include endolith DNA.A combination of microbes anti-cancer compounds and CRISPR killing or stunting their growth early on and conventional treatments such as immunotherapy,radiation,chemotherapy in less intensive measures early on alongside the primary symptoms should improve survival rates of all types of cancers dramatically with Epione,Paean,Gaia,Hecate,Urania and human researchers working together should eliminate cancer deaths significantly with genetic engineering of the human race via germline therapy.If perfected it would negate the need for radiation and chemotherapy as well as surgery.Thus these anti-cancer strains modified to detect biomarkers and CD47 will instantly attack tumours in their precancerous or stage 0 and 1 stage using the bloodstream and lymphatic system to reach hard to reach areas and even prevent tumours spreading.These microbes can also be used to in waves carry out CRISPR gene therapy treatments on the host patient via horizontal gene therapy including those to treat genetically predisposed cancers prior to and after instances of tumours forming and repair strands of DNA damaged from radiation,smoking and other carcinogens including oncovirurses such as HPV as well as ageing to deal with all types of cancers and those from scratch to deal with specific with them also using this transfer unique properties from extremophillic bacteria and other animals to increase the hosts ability to fight off,be immune to certain diseases and also tolerance to extreme environmental conditions giving living members of H.sapiens characteristics of H.ubermensch.Ideally the recombinant DNA from extrempphile bacteria inserted into patients who are recovering from the disease will include those from T.gammatolerans and D.radiodurans to make them immune to radiation and those from scratch to fix genetic predispositions and make them immune to all types of carcinogens with this eventually done to all living patients alongside germline therapy onto spermatozoa,eggs and embryos to make this a permanent feature of the human genepool eliminating the disease completely from humanity.Radiation therapy’s negative side effects could be counteracted by them producing vitamins,nutrients and other compounds that alleviate the strains put on the body and theoretically allowing ones hair to grow back or even prevent it falling out by soaking up excess chemotherapeutic compounds with them stimulating hair growth or prevent the the hair from being affected through CRISPR and hormones produced and even chemotherapy agents produced by the microbes and also applied to the patient can be flushed out of the system by combining them with other compounds created by them that bind to them make them benign and easily removed in urine and feces and/or breaking them down into nutrients or benign compounds or even soaking them up and releasing them into the bloodstream in short bursts to finish off any remaining cancerous cells and be flushed out or broken down by the bodies own systems over long periods of time.Ideally all patients will be made resistant to both chemotherapeutic compounds and radiation therapy through scratch DNA and also recombinant DNA from T.gammatolerans and D.radiodurans applied to all of the hosts cells via CRISPR with this removed from individual precancerous cells and tumours being treated by them and then reapplied to new healthy cells that are regrown in their place via the microbes to allow the patient to have treatments without any healthy cells being affected thus leading to side effect free conventional treatments.This would allow the tumours without radiorestant DNA to be exposed to extremely large doses of radiation of at least 500-2,000Gy with the surrounding tissue or indeed all of the patients organs to be free from any side effects at all thus allowing tumours to be killed easily and the tissue that grows in place of them have radiorestance readded.This if applied to all of the tumour over a large area to kill it all and prevent any residual tumours left to grow.Tumours could have this DNA from T.gammaloterans removed allowing the entire body to be hit with huge blasts killing the tumour but not affecting healthy cells.The same would apply to chemotherapy with immunity to drugs applied and then removed from tumours allowing for large doses of chemotherapy outside of those of Polybia-MP1 to be used.Organs,tissue and sections of organs can be regrown in vivo or as bioprinted organs.Any toxic chemotherapy compounds injected into the body and the compounds produced by the microbes that may pose a risk to human health in minute or high levels due to them released in floods can be dealt with the microbes applying genes from other animals and from scratch to every cell in the body or organs and tissues that it would negatively affect the most prior,during and after application to prevent the body being overwhelmed.The same would also be applied to drugs administered to treat tumours if still needed

The primary immune system can be used to fight tumours alongside microbes by having the patients bone marrow given CRISPR treatments that give the T cells the same capabilities as immunotherapy drugs that are made permanent by having the primary immune system be able to detect tumours especially those that are able to hide from or block attacks from them and help them synthesise better chemotherapeutic compounds including Polybia MP-1 and others created by conventional immunotherapy making this feature permanent with the primary immune system controlled by the microbes using chemical signals.The cancer strains of microbes can signal macrophages,natural killer cells to the site of tumours and have the dendritic cells called to the spot to gather proteins of dead tumours that are then sent to helper and killer T cells that are activated to fight off tumours.The cancer strains or immunisation strains can be used to enhance the primary immune system by grabbing parts of a tumour either alive or dead and sharing the tumours unique protein structure with dendritic cells to activate the primary immune system with this done to deal with tumours that mutate overtime to develop abilities to evade detection by having their unique proteins shared with the dendritic cells with them activating helper and killer T cells to deal with each generation of tumours.The immunisation strains can attach to each tumour and through horizontal gene transfer scan their DNA and through biosynths Wi-Fi have this sent to Phanes and Paean who will analyse the genome of the tumour for genes responsible for the unique surface proteins of the tumour through controlling the evolutionary path of taq polymerase through biosynth WiFi etc would have them house the genes specific to them be created in the anti-cancer strains that then like those for viruses and bacteria synthesise the unique surface proteins of tumours especially those that have developed methods to hide from the immune system and evaded initial attacks.The immunisation strains can through chemical signals from anti-cancer strains who can detect them be given the exact location of the tumours through chemical signals or biosynth WiFi inducing the evolutionary path of taq polymerase in immunisation strains to be able to detect tumours themselves.The unique surface proteins of each unique tumour on immunisation strains will be shared with dendritic cells who then share this with helper and killer T cells that have through CRISPR made stronger at fighting tumours with better chemotherapeutic compounds thus allowing the primary immune system devoted to fighting tumours attach tumours alongside the anti-cancer strains.The primary immune system devoted to fighting cancer er can have their actions controlled by the anti-cancer strains to know where to find tumours and when to attack them and how much chemotherapeutic compounds should be used and when to stop being used in order to prevent them overreacting and damaging the body with this collaborative effort increasing survival rates by destroying every single tumour until the body is cleared of them preventing new tumours arising from those that survive previous attacks with the ability of the anti-cancer strains to travel across the body allowing them to detect and fight off tumours that have spread or arisen across the body and signal the immune system that deals with cancer to their location immediately.As stated CRISPR can make immunotherapy a permenant part of the patients body without the use of immunotherapeutic drugs with CRISPR having inhibitor receptors on the primary immune system that deals with cancer from being affected by compounds created by tumours that shut them down thus preventing tumours shutting down the primary immune systems cancer defenses through them systesising compounds that do this.The inhibitor receptors of leukocytes that fight tumours can be modified permanently through CRISPR to be not only be unaffected by any type of compound created by tumours that shuts down the immune systems response but only be affected by those synthesised by the anti-cancer strains.This would allow the anti-cancer strains through chemical signals controlled by Paean to control all actions of the primary immune systems to wipe out every last tumour and prevent the primary immune system becoming lazy.The anti-cancer strains will work alongside the primary immune system by having Paean through biosynth WiFi have anti-bacterial strains synthesises chemical signals via inducing the evolutionary path of microbes through biosynth WiFi produce the genes in their genome that allows them to synthesise of the chemical signals for all leukocytes as part of the primary immune system to control them thus giving Paean the ability to indirectly control the primary immune system by using biosynth WiFi tell the anti-cancer strains synthesise chemical signals to control all actions of the primary immune system thus allowing the primary immune system to participate in battles against bacterial pathogens with all actions of the primary immune system to be controlled by Paean to speed up the battles and alleviate strains on the anti-cancer strains and prevent the primary immune system becoming lazy





Tumours and precancerous cells could also by using CRISPR be made to be susceptible and thus killed off rather than their growth stunted by the anti-cancer compounds at their disposal if they only stunt their growth with this done after the compounds first stunt their growth with the hosts made immune to the effects of these and these released as nanoparticles with bumpers.Parts of the immune system that deal with cancerous cells will work alongside these and will be enhanced by being able to detect tumours more easily and effectively through interactions and apply relevant anti-cancer compounds more effectively including the same ones produced by the microbes through CRISPR.The microbes ability to apply gene therapy and the ability to replace dying tissue with new ones will be applied to any cells and tissues that are damaged by any radiation and chemotherapy applied to the patient and also any tissues that were damaged by the tumour as it is removed and during its growth.Paean in a fragmented form will carry out simulations of all attacks of cancer a patient can get prior to them occurring to carry out countermeasures quickly or combined with Gaia,Epione and all university and hospital AIs around the doing with on all patients worldwide at once.Smokers,second hand smokers and others who have been exposed to carcinogens and also radiation at any time of their life may take tests and also x-rays using smart devices or in hospitals scheduled annually by Paean even years after the have given up smoking with genetic engineering allowing for all of the carcinogens removed from tobacco plants with a benign replacement for nicotine added that has the same flavour or better with this applied to all fruits,vegetables and recreational drugs.Toxic asbestos will be negated through the use of graphene and graphene paint in construction with existing buildings having it removed and replaced by graphene paint and graphene as well as non toxic fireproof hempcrete,hemp and fungi insulation.If possible gene therapy can allow DNA from T.gammatolerans and D.radiodurans to make people resistant to radiation such as those from UV sunlight that causes skin cancers,radiation from nuclear fallout and power plants as well as even cosmic radiation up to 30,000Gy compared to the 5Gy that humans are currently vulnerable to and further genes from scratch allowing for nicotine and other carcinogens to be flushed out of the body,unable to interact with their site of action without facilitating the growth of tumours.Bacteria with human DNA can be used as a means to develop new genes by exposing them to increased levels of each or all types of carcinogens to force them to evolve countermeasures to them that can then be added to humans as new genes with them used since they evolve more quickly than multicellular lifeforms.Until then microbes can create proteins that bind to them to allow them to be flushed out.The main anti-cancer compounds will be Polybia-MP1.Polybia-MP1s advantage is that it can kill off all types of tumours in a matter of seconds by attacking the unique phospholipids of tumours and causing key molecules for its survival to leak out with it not affecting healthy cells leaving no side effects thus allowing for its effects to be analysed by xrays and MRIs taken almost instantly after treatment or at least the next day rather than several weeks or months with conventional immunotherapy and chemotherapy used alongside it to enhance its effects in lower doses.TsAP-1 and melittin will be applied to stunt the growth of tumours using numbers and also when applied in the surface of tumours alongside CRISPR treatments to make the tumours responsive to them and thus allowing the Polybia-MP1 to kill it off instantly preventing them spreading around the body.Polybia-MP1 can be applied on the surface of tumours,by flooding it in the bloodstream since it doesn’t effect healthy cells but could require bumpers to prevent it breaking down in the bloodstream with melittin and TsAP-1 requiring bumpers that bounce off healthy cells and interact with only tumours and them also applied on the surface of tumours due to them having the potential to induce cytotoxicity and break down.Thus cancer will be treated and cured by anti-cancer strains inhabiting all tissues in the body detecting precancerous cells at least a decade before using universal receptors that detect biomarkers including CD47 and them applying anti-cancer compounds mainly Polybia MP-1,TsAP-1 and melittin that affect only tumours using bumpers and not healthy cells in bumpers and applied on the surface of tumours eliminating side effects using the bloodstream and lymphatic system to reach hard to reach areas that tumours reside in or in the process of spreading.TsAP-1 and melittin will stunt the growth of tumours while Polybia-MP1 is used to kill them off within seconds with also the option of them applying CRISPR treatments to kill them off via apoptosis or at least stunt their growth with them then removing the tumours accelerated healing genes via CRISPR in order to prevent it growing back if the DNA from A.mexicanum etc would cause destroyed tumours to grow back and then they would utilise Polybia-MP1 to kill off the tumour.Once the tumour is destroyed by Polybia-MP1 the stem cell strains would form new tissues in their place with them having the accelerated healing phenotype returned to the new cells with all patients worldwide will be inoculated with anti-cancer strains even if they have no predispositions to it.If need be genes associated with anti-ageing such as Bacillus F,T.gammatolerans etc can be removed and then added back once the tumour is destroyed though endolithic DNA may be kept as it could slow tumourgenesis and the growth and spread shown in animal trials and tissue samples.TsAP-1 and mellitin have the potential to induce cytotoxicity that is they can cause damage to healthy cells and thus should be avoided by anti-cancer strains with if they are ever used they should be applied using bumpers that apply them onto the surface of tumours and bounce off healthy cells.Polybia-MP-1 however has shown in peer reviewed scientific studies to have no side effects and thus should be the main compound to be used by anti cancer strains with it thus synthesised by the anti cancer strains using recombinant DNA from P.paulista in the bloodstream and lymphhatic system in order to allow it to flood them to travel to all parts of the body.However it could break down in the bloodstream abd thus may need bumpers to prevent it breaking down in the body and it can also be synthesised on the surface of tumours.These anti-cancer strains and the compounds will be able to cure patients of all stages 0-4 and all types of the disease by 2029.Ideally those found to have genetic predispositions to specific cancers can have CRISPR treatments to correct these mutations by adding and removing genes in all cells in the body once detected by genetic screening and familial history decades before they form to correct the defects reducing or removing their chances of developing it with it dealt with by the microbes if they appear.This would be done in both adults and infants to again remove any chance they have developing that form of cancer decades before they form with them treated by 2025-2029

DNA scans and proto patient files by 2023/2024 will automatically schedule them for not only routine check ups immediately but to also have them treated with modified Car-T immunnotherapy using Polybia-MP1 etc but also for for human trials in 2025 for anti-cancer strains and CRISPR treatments to remove these genes.Adults with these predispositions and smokers and those exposed to carcinogens will before this undergo routine MRI scans to detect tumours early on for surgery,radiation and chemotherapy to be less intensive with ideally Car-T immunotherapy utilising Polybia MP-1 etc and CRISPR treatments being used first with the same applying to those who have had recovered to cancer in the past especially recent and also those undergoing chemotherapy with those with terminal cancer also undergoing this treatment.These proto treatments will also be availible for those who develop cancers due to smoking,radiation etc.Those recovering from it will have any damaged genes corrected in any cells by base microbes scanning all cells in the body or relevant cells in the area where they were located.This can be done while the cancer cells and the entire persons tissues treated with CRISPR to correct mutations that lead to genetically and environmentally caused cancers or even those that render the patient to be unable to get cancer again using scratch DNA.

If possible scratch DNA can be added to a persons genome to allow the primary immune system be able to detect and fight off tumours early on in their precancerous stage with if possible the primary immune system housing tweaked C.elegans DNA and recombinant DNA from P.paulista to allow them to detect cancer bio markers early on before they develop into tumours and have the body produce Polybia-MP-1 to kill the tumours within minutes.

The presence of DNA repair mechanisms of T.gammatolerans,Bacillus F and D.radiourans DNA that rejuvenates telomere degradation,repairs mutations and possibly the proliferating cell nuclear antigen and also DNA excision repair protein ERCC-1 genes and those from scratch and even A.mexicanum added to humans may prevent the formation of cancers if applied to all humans worldwide with trials in mice and chimpanzees showing this when they have human recombinant DNA and are exposed to both radiation of all types and also all types of carcinogens.This would instantly repair any mutations and breaks caused by carcinogens,radiation and also mitosis of cells.The same extremophile bacteria DNA used to reverse and halt the effects of ageing will possibly prevent them being passed onto future generations by repairing mutations that cause those that lead to cancer.Further genes from scratch could make cells immune to chemical carcinogens.The recombinant DNA from T.gammatolerans,D.radiourans would also make humans resistant to radiation of up to 30,000 Gy compared to 5Gy thus ensuring radiation from nuclear isotopes of elements such as uranium,plutonium etc,from xrays,radioactive fallout and waste and also from UV radiation will not affect humans at all thus allowing them to survive huge blasts that would cause tumourgenisis eliminating skin and indeed all cancers caused by radiation and repair any that are caused by mutations and carcinogens.To counteract the immunity to the suns UV radiation patients could using CRISPR treatments have a desired skin tone to be created by melanocytes thus allowing them to have this anytime of the year for as long as they want.Scratch DNA and those from bacteria in labs exposed to high levels of all types of carcinogens forcing them to evolve countermeasures and immunities to them thus allowing these new genes to be applied to humans can be utilised.Thus bacteria since they evolve more quickly will be exposed to high levels of each individual carcinogen and those that gain an immunity to high doses will be scanned for new genes that can be added to humans.DNA from endoliths as part of anti-ageing treatments could slow the development of tumours by centuries or millenia or preventing them happening by slowing miotic rates and/or even prevent uncontrolled cell division and any mutations caused by mitosis and carcinogens alongside those from extremophiles that dont exhibit uncontrolled miotosis at all as well as those from scratch to prevent this.This should be analysed as possible gene therapy to prevent cancer arising in the human genepool ever again instead of using DNA from Elephantidae,H.glaber and similar mammales that do not get cancer as a less complicated mechanism that doesnt accelerate ageing or indeed need the use of other extremphile DNA alongside other.As stated both measures ie using extremophile bacteria,scratch DNA,the proliferating cell nuclear antigen and also DNA excision repair protein ERCC-1 genes on one set of animals as well as human tissues and those from H.glaber etc in another set of animals and human tissues at the same time should be applied in both animal and human tissue trials as early as 2023/2024 with both on specimens with and without ageing treatments applied.The decided DNA will be added to both the mitochondrial and telomere DNA with ideally it being those from T.gammatolerans,Bacillus F,scratch DNA,the proliferating cell nuclear antigen,DNA excision repair protein ERCC-1 genes as well as endolithic bacteria combined as they would repair any random breaks that occur due to carcinogens,random mutations during mitosis etc instantly and are more simple than the complicated measures utilised by H.glaber which may not be applicable to humans and also could cause complications.Tests on animals using different sets of animals using genes from ,T.gammatolerans,Bacillus F,scratch DNA and others using the proliferating cell nuclear antigen,the homology directed repair mechanism ie homogulous recombination derived from embryonic stem cell DNA,DNA excision repair protein ERCC-1 genes by themselves as well as in different combinations and combined in different sets that are then exposed to different carcinogens including radiation should determine the genes used that can be best applied to humans with no side effects,less complicated mechanims etc with it ideally being those from endoliths scratch DNA as this would negate the need for extra DNA added since these would combat ageing and have simple mechanims such as telomere repair.Other genes from scratch can be added to prevent all cells making telomrase in out of control levels that can lead to tumours.Ideally DNA from T.gammatolerans,Bacillus F and possibly scratch DNA and others using the proliferating cell nuclear antigen,the homology directed repair mechanism ie homogulous recombination derived from embryonic stem cell DNA,DNA excision repair protein ERCC-1 genes will be used ideally by themselves if not together in different combinations in order to eliminate a forms cancer from the human gene pool forever due to them having fewer genes and also less complicated mechanisms that may be more applicable to human patients than that of other animals.If possible the telomere repair mechanisms of T.gammatolerans may only need to be used and would be ideal as it also protects one from radiation.DNA from T.gammatolerans etc used to slow or halt and even reverse the ageing process may by itself prevent the formation of tumours due to their nature of telomere repair mechanism and slowing the growth of tumour growth meaning it would prevent tumours occurring due to radiation,carcinogens,random breaks in miotic cell division etc thus negating the need to add extra DNA strands to them with this involving less complicated repair mechanisms.This will wipe all forms of cancer from the human genepool by the early to mid 2030s if applied to all living patients worldwide passing from one generation using advanced gene drive technology and germline therapy by making it impossible for tumours to form via carcinogens,radiation,random breaks and repairing DNA caused by mutations that leads to genetic based cancers and so on.Scratch DNA would also be developed by Phanes to do this.Anti-ageing treatments would negate any chance they could form.Carrying out both on human tissues and animals at the same time starting by at least 2023/2024 should allow for the best method to all forms of the disease from the human genepool by at least the mid 2030 to 2040s if applied to all patients worldwide via advanced gene drive technology to be determined.Animal trials would start as early as 2024-2025.Tissues that were affected by chemotherapy,microbial action,radiation and surgery will be regrown via the microbes with any organs such as ovaries,uterus and breasts removed will be bioprinted or grown from scratch in vivo and in vitro.Any oncoviruses present in the body that hide in the bloodstreamm and any cells will be destroyed using the same methods as treating viruses with any DNA from these left in cells destroyed or removed via CRISPR as well as destroying the cells by making them undergo apoptosis and then replace them with fresh ones though ideally cancers that arise from oncoviruses should be avoided by immunising the host from them with them also either made to undergo apoptosis and replaced with new tissue or the uninfected patients being edited to be unable to be infected.

To deal with esophageal and stomach cancer those who have a genetic predisposition determined by genetic scans the lining off the esophagus and stomach can be altered by these to have recombinant DNA from acidophiles added to their genome to make them resistant to the effects of acid reflux with CRISPR correcting mutations leading to this or creating flaps over the stomach via stem cell microbes forming tissues or CRISPR treatments or surgery using bioprinted flaps to prevent acid reflux with these again resistant to acid.Those with a predisposition to GERD will have proper flaps over the stomach produced by stem cell strains carrying out in vivo cosmetic surgery,robotic surgery and possibly CRISPR treatments to correct the mutation and initiate the proper formation of these.Adding recombinat DNA from acidophiles added to all patients preventing GERD and stomach ulcers protecting the stomach and oesophagus against stomach acids with all patients also immunised against H.pylori and oncoviruses.Those with existing damage from the acid reflux will have tissue replaced by them formed over the scarred ones by stem cell strains or have bioprinted ones replaced over them added by surgery.The accelerated healing phenotype will heal any scarring that occurs and prevent tumourgenisis in future patients by 2029.Having both the stomach and oesophagus fitted with this DNA will also protect others from acid reflux and heartburn and thus stomach and esophageal cancer as well as similar conditions with this preventing damage to these organs in buliamics with if all cells fitted this would protect the stomach and oesophagus and all parts of the gastro intestinal tract from the ingestion of acids and the outer skin and eyes from acids that would otherwise cause serious burn.Immunotherapy and oncolytic virus therapy due to its promising success rates in recent years against all types of cancer should be used as the first line of defence against all types of cancer in all patients with patients worldwide getting genetic screens to determine what cancers they are prone to and also getting tested regularly including those in their early teens and being vaccinated against oncoviruses and avoiding smoking and other carcinogens until microbes are perfected.

Those with genetic predisposition to all types of cancers through genetic screening should have routine check ups and early treatment through traditional immunotherapy applied to them when they get cancer with women prone to cervical cancer and also those not vaccinated against oncoviral strains of HPV given this until microbes are prepared and then have gene therapy to add or remove genetic predisposition.This is because it would attack tumours in their early stages and at least make radiation and surgery less intensive and the Car-t immunotherapy would have DNA from P.paulista.These patients will be scheduled for frequent check ups in hospitals every few years or months depending on the type of cancer to catch early symptoms of the disease.They will also be scheduled for CRISPR treatments that add or remove genes that predispose them to cancers by 2029.Those who have already undergone hysterectomies and mastectomies etc will have these organs regrown invivo later by layer by the stem cell microbes creating new tissues and CRISPR to initiate their natural regrowth and have CRISPR treatments to remove the cancer causing genes.All teenage girls and men who have sex with men should be vaccinated and in time immunised against all oncoviruses especially HPV before microbial immunisation is possible with older women also immunised this to prevent most cases of cervical cancer with this providing lifelong protection.Ideally though when immunisations become possible all patients worldwide will be immunised against all strains of HPV and other oncoviruses to prevent this causing oncobiral based tumours with those infected with non oncoviral strains of HPV will be immunised against them and their existing ones and these in already infected patients of all strains will be fought off in infected patients to prevent them spreading them to others.In time by 2029 newborns alongside all adults and adolescents of both genders will be immunised against all known oncoviruses alongside adults.Those who got cancer from existing strains of HPV or have already been infected with non oncoviral strains can be immunised against them and the anti-viral strains using CRISPR to make them susceptible to all compounds in those already infected with both oncoviral and benign strains.Ideally all patients world wide will be immunised against all oncoviruses.

If possible all existing immunotherapy methods including Car-T cell immunotherapy and also Poliovirus methods would use Polybia-MP1,melittin and TsAP-1 acting as a vector for the compounds due to their effectiveness at transporting existing compounds thus if combined with Polybia-MP1,melittin and TsAP-1 could be ideal at transporting these due to their ability to kill tumours so efficiently.This should be effective against all types of cancers.Using viruses that are tweaked to detect and intercept tumours such as as with what is done with Herpesviridae and the Poliovirus can also be done alongside modified immunotherapy methods that both use Polybia-MP1,melitin,TsAP-1 particularly in them releasing the Polybia-MP1,melittin and TsAP-1 into the tumours or its surface until microbes are perfected increasing the effectiveness of these methods.Thus viruses can be used that are coated with human DNA and can only interact with tumours to insert Polybia-MP1 alongside its DNA into the tumour to kill it with the protein coat protecting them in immunised individuals.If possible ones own leukocytes as part of Car-T cell treatments can be using the disarmed virus via CRISPR used to create not just receptors on them but to have them also produce Polybia-MP1 with other forms of immunotherapy modified to use this compound due to its effectiveness at killing cancer with this and injections used to kill off any relapsing tumours.Immunotherapy could be modified to create primitive microbes in the form of modified marcrophages that are hybrids of these and cancer killing T-Cells as well as B and T helper cells all of which can fight off superbugs as well as cancers by themselves or injecting chemicals to activate them.Bacteria can be used once disarmed and have human protein coats with human DNA in them to prevent immune responses can be fitted to use Polybia-MP1 that are tweaked to detect CD47 to locate tumours in hard to reach areas to apply it in nanoparticles and reawaken the immune system.Viral vectors should also have human DNA and thus protein coats in them to prevent immune responses.All types of immunotherapy especially Car-T,use of the Poliovirus can be modified to utilise Polybia-MP1,melittin and TsAP-1 due to its effectiveness with trials on humans that involve simple injections of the Polybia-MP1 and TsAP-1 etc compound itself covered in bumper proteins starting in at least by 2023/2024 on all types of cancer whether stomach,brain or even cervical cancers with hard to get rid of cancers using all of these in combination with each other to first wipe out tumours with chemotherapy and radiation being less intensive.This would be of benefit to those with terminal cancers as well with the immunotherapy first applying TsAP-1 and melittin via this method at first one after the other or at the same time to stunt the growth and spread of tumours and them allow immunotherapy utilising Polybia MP-1 to be used in conjunction with less intensive radiation and chemotherapy and also surgery to increase survival rates amongst both terminal and early stage patients drastically.3D DNA printing will play a role in creating viral and immunotherapy vectors to quicker the rate of their development for those currently suffering from terminal and even early stage tumours.CRISPR treatments to halt the spread of tumours can be done alongside those that cause it to undergo apoptosis with these applied via modified Car-T immunotherapy and also both viral and bacterial vectors with the viruses and bacteria used should be programmed to undergo apoptosis once the compound and CRISPR treatments is deployed.Ideally it should be used as a trial for stage 2 to 4 as well as inoperable tumours and those with terminal cancers.Ideally modified Car-T immunotherapy where Car-T treatments using macrophages as well as the Polioviruses etc carry,inject and produce the Polybia-MP1,meilittin and TsAP-1 to the site of tumours killing them instantly improving immunotherapy success on all types of cancers that immunotherapy has limits on using recombinant DNA from P.paulista and viral vectors such as Polioviruses and bacteriophages that also uses the same recombinant DNA to carry the compound to the site of tumours in hard to reach places etc combined with each other.Viral,bacteriophage and Car-T vectors could be used to transfer CRISPR treatment to cause tumours to undergo apoptosis,become more susceptible to the venoms if not and halt their growth as well.Both viruses and Car-T can utilise 3D DNA printing to add the relevant DNA from P.paulista and T.serrulatus alongside conventional methods to speed the process up and reduce costs.This modified immunotherapy and viral vectors that transports Polybia-MP1,meilittin and TsAP-1 to tumours will all be availible by at least 2023/2024 and allow those with and who will develop terminal and severe cancers to survive long enough to avail of full anti-cancer and anti-ageing strains and also gene therapy to eliminate cancer from their body and genepool by at least 2029-2035.Ideally it should be a first line of defence on all types of cancers from stage 0 to 4 including those with terminal cancers with both existing patients with terminal cancers and those currently underoing chemotherapy and conventional immunotherapy can undergo this at the same time that they are undergoing conventional treatments as early as 2024.Thus the use of viral vectors such as Poliovirus,Herpesviridae, and modified Car-T immunotherapy that utilise melittin,Polybia-MP1 and TsAP-1 and CRISPR treatments will be carried out alongside conventional treatments including chemotherapy,radiation to ensure they at least work alongside them to compliment and enhance them but not replace them in these trials for human patients begging as early as 202/2023 with animal trials involving animals with human recombinant DNA to produce all types of cancers using modified Car-T immunotherapy,viral vectors starting at this period to test its effectiveness by itself in treating all types of cancers in all stages to be applicable to human trials and full versions by itself by at least 2025-2029 can be used to replace radiation and chemotherapy as a first line of defence until full microbes can be developed.These immunotherapy treatments will first have them apply melittin,TsAP-1 to stunt the growth of tumours making chemotherapy and surgery more effective and also allow immunotherapy involving Polybia-MP1 alongside chemotherapy to be more effective.Polybia-MP1 and other anti cancer compounds can be delivered t the site of tumours using modified Car-T immunotherapy and viruses that are able to kill tumors.Both Car-T immunotherapy and viruses such as have already shown to destroy tumours with major success over radiation and chemotherapy in certain cancers and their drawbacks and imitations can be countered by them transporting these compounds increasing survival rates for all types of cancers up to 100%.It is simply a case of merging these existing technologies and the compounds together by having modified Car-T immunotherapy,bacteriophage and viral vectors house recombinant DNA from these animals and have them act as vectors for CRISPR treatments and the compounds.3D DNA printers onsite of hospitals and universities worldwide combined with AI can expedite the manufacture of viral vectors and modified Car-T immunotherapy as they can be produced onsite of all hospitals around the world by at least 2023-2025 for human clinical trials.DNA of Herpesviridae,Poliovirus,P.paulista,T.serrulatus in existing databases can be analysed by AI with traces of the patients DNA utilised to prevent rejection.If possible bacteriophage/virophage DNA can be added so that these viruses and Car-T immunotherapy treatments use tumours as replication vectors meaning every time it infects a tumour it replicates exponentionally and then infects other tumours until all tumours are destroyed and clears from the body.This could as a proto cure for current terminal cancer patients prior to the cancer strains being perfected.

Bacteriophages can be created by AI and 3D DNA printers that are tweaked to directly use all or specific tumours or all types of cancers as replication vectors that once destroyed are unable to spread or regrow thus eliminating them from the body completely which the bacteriophages engineered to use only tumours and not normal healthy cells as replication vectors via scratch DNA that can only interact with and seek out only tumours and once DNA etc is inserted into the tumour it uses it as a replication vector that once it created thousands of new bacteriophages that to destroy the tumours then creates specific endolysines that can destroy tumours from the inside out that then create exponentionally more of these bacteriophages that then actively seek out other tumours across the body especially in cases of tumours that have spread across the body that then exponentionally destroy all tumours in the body including those that have spread until the body is completely cleared.These would would be designed by AI analysing existing bacteriophages that then are modified to seek out and interact only with tumors and their unique surface proteins as well as detect cancer biomarkers and use them as replication vectors with them avoiding healthy cells and flushed out of the body once it has been cleared of tumours with AI and 3D DNA printers expediting research into them.These will be injected into the bloodstream at the site nearest to where tumours are to cure patients quickly with this done at multiple sites to cure them exponentially quicker.Tumours that are engineered to grow on a solid or liquid media in vats etc using a nutrient broth can be used to grow them onsite of hospitals thus allowing the bacteriophages to be injected into the media that had large amounts of tumours present that use them as a replication vector that is full if nothing but bacteriophages once all tumors are destroyed.These tumours will be created by analysing tumours and them have genes added to cells created by 3D DNA printers to make them grow on this media allowing large amounts of tumours time be created onsite of hospitals in vats.Photobioreactors will grow large amounts of separate tumours with the media being agar media or either sugars and proteins created by genetically engineered bacteria with the vats once enough of the tumours are grown will have the bacteriophages added crested by 3D DNA printers that will then use them as replication vectors until all tumors are gone and all is left are trillions or more bacteriophages that can be then extracted and injected into vials making hospitals self sufficient in their manufacturing..These bacteriophages would use the lymphatic system and also the entire bloodstream such as major arteries,veins and capillaries to travel across the body and destroy tumours.It can be a proto cure to cure stage 0-4 before it developing anti-cancer strains that will at least halt the spread of serious deadly cancers and keep it in check.

.CRISPR treatments can be applied to tumours via bacteriophages,proto microbes and the aforementioned viruses that stunt the growth of tumours,cause them to undergo apoptosis and remove genes key to their survival such as those releated to telomerase with bacteriophages and Poliovirus and Herpesviridae used to transport them to act as a backup.These bacteriophages and viral vectors etc will be ideally injected near the site of tumours such as near the neck for brain tumours and near where other tumours are to increase the speed at which they interact with and destroy tumours.For advanced forms of cancers that have spread to multiple parts of the body they can be injected at multiple points of the body to attack multiple parts at once thus expediting the rate they clear the body of tumours.Thus by at least 2023-2025 those who have been and will be diagnosed with terminal cancers or even easily treatable ones of all types in their early and advanced stages will undergo clinical trials using Car-T immunotherapy,those using the Poliovirus and Herpesviridae and bacteriophages to act as a vector to transport melittin,TsAP-1 and Polybia MP-1 to the site of tumours and use tumours as a replication vector using relevant recombinant DNA from the aforementioned arthropods alongside conventional treatments such as immunotherapy,radiation and chemotherapy etc to increase their survival rates until both anti-ageing and anti-cancer strains are availible by 2029.3D DNA printers onsite of hospitals and universities worldwide and AI will expedite research and development onsite of hospitals worldwide making them available by 2025 if not earlier by mid to late 2023/2024 allowing those currently diagnosed with terminal cancers to survive long enough for more advanced treatments and also anti-ageing strains.Thus Poliovirus and Herpesviridae both covered in human proteins coats to prevent immune reactions and modified Car-T immunotherapy treatments can be used as vectors that transport TsAP-1,mellittin that stunt the growth of tumours and Polybia-MP-1 that destroys them to the site of tumours preventing toxicity and them breaking down will be availible by at least 2025 or even by 2023/2024 worldwide by simply adding the relevant recombinant DNA from P.paulista and T.serrulatus available in genetic databanks across the world will be able to theoretically increase survival rates for those currently battling or who will develop terminal stage 3 or 4 cancers of all types to allow them to avail of them for clinincal trials with them also used for transporting genes that remove the tumours ability to produce telomerase and key nutrients and compounds that are key to their immortality and even survival,suicide genes from terminator seeds used by Monsanto,endolith DNA that slows their mitosis and growth,those from scratch that even make tumours susceptible and killed off by natural compounds that are non toxic to healthy cells that can consumed or injected into the bloodstream and spread by the bloodstream.These viruses can also be engineered to utilise tumours as replication vectors using DNA from HIV,Coronavirus and scratch DNA that infect and destroy only tumours exponentially.Bacteriophages covered in human proteins coats to prevent immune reactions can be modified to transport these CRISPR treatments and also even these compounds such as TsAP-1,mellittin and Polybia-MP-1 to the site and genome of tumours.This should ensure those currently suffering from and who will develop terminal and severe cancers as of 2023/2024 will survive long enough to avail of human trials of cancer and ageing strains of microbes by 2025-2029.The ability of these compounds to destroy tumours within seconds in the case of Polybia-MP1 and inhibit growth of them in the case of mellittin and TsAP-1 has already been proven in lab settings and these viral and Car-T vectors that have already been shown to be successful at transporting anti-cancer compounds thus meaning they can be merged together and the vectors modified to house the relevant recombiant DNA with viral vectors used to transport melittin and TsAP-1 directly to the site of tumors stunting their growth without them inducing cytotoxicity to stunt their growth with both viral vectors and modified Car-T immunotherapy used to transport Polybia-MP1 to prevent it braking down as unlike the other two compounds it does not induce cyto toxicity with this merging preventing the o of existing technologies and working on the strength of both.Thus AI and 3D DNA printers onsite hospitals and universities worldwide combined can expediate the manufacture of Car-T immunotherapy using 3D DNA printed macrophages or even bacterial vectors and viral vectors including Poliovirus,Herpesviridae and bacteriophages all covered in human proteins that transport Polybia-MP1,TsAP-1 as well as melittin using recombinant DNA from P.paulista,A.mellifera,T.serrulatus for stage 3 and 4 terminal patients to make proto treatments to be availible by at least 2023/2024 as part of clinical trials to cure them or extend their life long enough to live long enough to 2029 when full version anti-cancer strains are availible provided enough work is done by human researchers and AI such as proto Phanes scanning genetic databases and creating these viral,bacteriophage and Car-T immunotherapy since the relevant DNA of these animals that express these compounds should already be in genetic databases with 3D DNA printers onsite of all hospitals and universities worldwide allowing for expediated and localised manufacturing for all afflicted patients worldwide.These will be utilised alongside conventional chemotherapy,immunotherapy and surgery to enhance them before replacing them by 2029.

Since the compounds attacks only cancerous cells it should be effective on all types of cancers and as stated does not affect healthy cells meaning trials on humans with severe terminal cancer alongside conventional treatments should be as early as 2023/2024.Ideally this combined with modified and conventional immunotherapy should replace existing chemotherapy and radiation complete until microbes become sufficiently advanced that would prevent it breaking down to treat stage 3 and 4 cancers as well as inoperable and terminal tumours and hard to reach ones that can or have easily spread as well as preventing tumours spreading as well.If injected as stated in large amounts via intravenous drip similar to most chemotherapy by itself or in proteins and even when bonded to existing chemotherapeutic drugs that interact only with tumours and prevent it degrading and guide it more effectively to tumours it can use the bloodstream and lymphatic system to spread to all parts of the body especially hard to reach parts of the body such as the brain,cervix,prostrate and deal with those that are inoperable,terminal and stage 2 to 4 especially if pumped into the patient in large amounts with excess flushed out of the body with this done alongside immunotherapy.This would also prevent tumours spreading to other areas of the body.It could in the case of early stage tumours be injected close to its site under the skin directly above where it is or use the circulatory system.Simply swallowing as a liquid if it can survive the stomachs acids would allow Polybia-MP1 to treat stomach and esophageal cancer as well as allow it to travel to other parts of the body via the bloodstream as well as sterilise the stomach of H.pylori with it otherwise injested as a pill.Protein bumpers covering it could allow it to survive the stomach,bloodstream and interact with only tumours.If possible it can be injected into the bloodstream and also injested in pill or liquid form like most antibiotics to allow it to kill of bacterial pathogens such as MRSA especially other resistant bacteria with it being part of strains of microbes used to fight bacteria.Mellitin and TSAP-1,TSAP-2 since they can cause potentially fatal reactions with normal healthy cells would if injected would require bumpers with Polybia-MP-1 needing it to prevent it breaking down in the bloodstream.Polybia-MP1 unlike Mellitin,TSAP-1,TSAP-2 is known not to cause cytotoxicity that is it only affects tumours and not healthy normal human cells so even if injected or injected into the bloodstream it should be safe with it unknown as to whether it breaks down in the body with if it does then it may need protein bumpers to transport it around the body without breaking down with bumpers needed to transport mellitin,TSAP-1,TSAP-2 etc to prevent cytoxicity.Using drip injection of the compounds into the bloodstream should ideally at first be tested on animals by 2023/2024 and then for humans with stage 0-2 cancer at least by 2025 since it is using unproven effects of transportation with modified Car-T immunotherapy and viral vector treatments tested on stage 3-4 patients with terminal cancers by 2023/2024 due to these transportation methods being more readily tested and proven.These viral vectors and bacteriophages would through being created by 3D DNA printers would house the patients own DNA DNA to prevent them illicitating an immune response.Macrophages as part of Car-T immunotherapy created by 3D DNA printers would be house the patients own DNA to prevent it illicitating an immune response with ones DNA analysed in a lab before this is done to have the 3D DNA printers be able to print ones DNA to express patient specific surface proteins to prevent the body recognising it as an virus,bacteriophages or foreign macrophage thus allow them to kill tumours without illicitating immune responses that could be either fatal or render them ineffective.3D DNA printers onsite of hospitals would expediate the manufacture of bacteriophages,viral vectors and modified Car-T immunotherapy making them available for human clinical trials as early as 2023/2024 or at least 2025 that will improve the survival rates of patients with advanced stages and forms of the disease to avail of full form anti-cancer strains.Gene therapy as stated using D.radiourans,T.gammatolerans,Bacillus F etc DNA and its relatives will wipe all forms of cancer from the human genepool by the early to mid 2030s if applied to all patients using advanced gene drive technology and germline therapy by making it impossible for tumours to form via carcinogens,radiation,random breaks and repairing DNA that leads to genetic based cancers and so on.These strains would ideally in all patients to allow for any tumours that occur by pure chance to fought off within a matter of seconds without the person realising it and would be by law free.These anti cancer strains through using these anti-cancer compounds and venoms and CRISPR treatments will act as cure for all types cancer in all stages.

Similar to how the AIs Gnome and Alpha fold were able to extrapolate millions of new proteins and nanomaterials within hours expediating scientific advancement by 800 years in a few hours Phanes and Paean even in a proto form or both Gnome and Alpha fold will be able to similarly extrapolate millions of antibodies,synthetic compounds and genotypes to express them for each individual type of cancer.They can also scan Physis for genes in all species of animals,plants etc and extrapolate what each individual gene expresses to determine anti-cancer compounds with them also extrapolating synthetic anti-cancer compounds that can be synthesised by scratch DNA and anabolic and catabolic reactions